センソニーニューラル聴力障害に対する完全に埋め込み可能な補聴器.

[Tracheotomy or planned prolonged intubation after surgery for patients with OSAS].

HNO·2014

[Personalized molecular medicine: new paradigms in the treatment of cochlear implant and cancer patients].

HNO·2014

[Palliative medicine].

HNO·2012

Totally implantable active middle ear implants: ten years' experience at the University of Tübingen.

Advances in oto-rhino-laryngology·2010

Deficient membrane integration of the novel p.N14D-GJB2 mutant associated with non-syndromic hearing impairment.

Human mutation·2006

[Laser-based quality assurance for robot-assisted milling at the base of the skull].

HNO·2005

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Spike-Driven Neuromorphic Sensing for Energy-Proportional Indoor Air Quality Monitoring in Multi-Zone IoT-Enabled Smart Building Environments.

Sensors (Basel, Switzerland)·2026

A 0.0075 mm<sup>2</sup>, 0.0139 FoM Double-Ring Vernier TDC with Vernier Arbiter Phase Calibration and Code Error Cancellation for 26 dB SFDR Improvement in ToF-PET.

IEEE transactions on biomedical circuits and systems·2026

Online food delivery and body weight: Quasi-experimental evidence from China.

Journal of health economics·2026

A Chopper Amplifier with Feedforward SAR ADC Assisted DC Servo Loop Achieving ±1V DC Offset Cancellation in 2.1s for Neural Signal Recordings.

IEEE transactions on biomedical circuits and systems·2026

Reliability-Aware Microsystem Design; Compensation for an Ultra-Low-Power Current-Reuse LC-VCO.

Micromachines·2026

Modern Potentiostat Architectures for Electrochemical Sensing: Design, Integration, and Future Directions.

Micromachines·2026

関連する実験動画

センソニーニューラル聴力障害に対する完全に埋め込み可能な補聴器.

関連する概念動画

[Tracheotomy or planned prolonged intubation after surgery for patients with OSAS].

[Personalized molecular medicine: new paradigms in the treatment of cochlear implant and cancer patients].

[Palliative medicine].

Totally implantable active middle ear implants: ten years' experience at the University of Tübingen.

Deficient membrane integration of the novel p.N14D-GJB2 mutant associated with non-syndromic hearing impairment.

[Laser-based quality assurance for robot-assisted milling at the base of the skull].

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Spike-Driven Neuromorphic Sensing for Energy-Proportional Indoor Air Quality Monitoring in Multi-Zone IoT-Enabled Smart Building Environments.

A 0.0075 mm<sup>2</sup>, 0.0139 FoM Double-Ring Vernier TDC with Vernier Arbiter Phase Calibration and Code Error Cancellation for 26 dB SFDR Improvement in ToF-PET.

Online food delivery and body weight: Quasi-experimental evidence from China.

A Chopper Amplifier with Feedforward SAR ADC Assisted DC Servo Loop Achieving ±1V DC Offset Cancellation in 2.1s for Neural Signal Recordings.

Reliability-Aware Microsystem Design; Compensation for an Ultra-Low-Power Current-Reuse LC-VCO.

Modern Potentiostat Architectures for Electrochemical Sensing: Design, Integration, and Future Directions.

関連する実験動画

センソニーニューラル聴力障害に対する完全に埋め込み可能な補聴器.

関連する概念動画

関連記事